Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

More research is needed to standardize and prove the effectiveness of platelet-rich plasma treatments.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

FLCN helps control iron levels in cells.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

PRP combined with other treatments shows promise for skin rejuvenation.

Platelet-rich plasma improves skin flap survival by reducing tissue death.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Melatonin-loaded nanoparticles improve antidepressant effects and HPA hormone balance better than regular melatonin.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Platelets and their derivatives, like PRP, can help tissue regeneration, but need standardized safety protocols.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Poly-L-lactic acid injections can cause hair loss and skin issues.

Changing the amount of PLC5 in Arabidopsis affects root growth and drought resistance, with less PLC5 slowing root growth and more PLC5 improving drought tolerance but hindering root hair growth.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

The new nitric oxide delivery system may effectively treat hair loss by improving hair follicle health and reducing inflammation.